The North American Chinese Clinical Chemists Association (NACCCA) is pleased to announce the successful completion of its annual board elections for the 2023-2024 term. A robust turnout of members from various regions and countries participated in the July elections, reinforcing the global nature of our organization and commitment to a shared future in clinical laboratory medicine.

The newly-elected board, with a mix of seasoned and emerging leaders, will serve to enhance the NACCCA's mission of promoting academic, developmental, and service excellence in the practice of clinical laboratory medicine through education and information exchange.

We are honored to present the dedicated professionals forming our 2023-2024 Board:

Immediate Past President: Dr. He Sarina Yang

President: Dr. Fang Wu

President-Elect: Dr. Qian Katie Sun

Secretary: Dr. Rongrong Huang

Treasurer: Dr. Min Yu

Board of Directors: Dr. Li Wang; Dr. Zhicheng Jin

Collaboration Development Officer: Dr. Yiqi Ruben Luo

Communication Officer: Dr. Amy SiawLi Chan

Scientific Advisors: Drs. Yan Victoria Zhang, Zhen Zhao, Xin Yi

Historian: Drs. Jing Cao, Young Wang, Chao Yuan

Dr. Fang Wu, newly elected President, shared her sentiments, "It's an honor to be elected as the President of the NACCCA. We have a dynamic group of individuals on the board, bringing together a rich diversity of experience and expertise. I am confident that we will continue to advance the field of clinical laboratory medicine."

The NACCCA extends its heartfelt appreciation to the outgoing board for their invaluable contributions and steadfast service. Their relentless efforts have established a robust foundation upon which the new board will continue to build.

Looking ahead, the Association anticipates a prosperous year under the new leadership. NACCCA remains committed to upholding professional standards and practices, fostering an environment conducive to knowledge and skill exchange among its over 500 members worldwide.